The role of apoptosis, immunogenic cell death, and macrophage polarization in carbon ion radiotherapy for keloids: Targeting the TGF-β1/SMADs signaling pathway.

Apoptosis Carbon ion radiotherapy Immunogenic cell death Keloid fibroblasts Macrophage polarization TGF-β1/SMADs

Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 04 05 2024
revised: 11 08 2024
accepted: 23 08 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 8 9 2024
Statut: aheadofprint

Résumé

Keloids, characterized by excessive extracellular matrix (ECM) deposition and aberrant fibrous tissue proliferation, present significant therapeutic challenges due to their recalcitrant and recurrent nature. This study explores the efficacy of Carbon Ion Radiotherapy (CIRT) as a novel therapeutic approach for keloids, focusing on its impact on fibroblast proliferation, apoptosis induction, immunogenic cell death (ICD), macrophage polarization, and the TGF-β/SMAD signaling pathway. Utilizing a murine model of keloid formed by subcutaneous injection of zeocin in C57BL/6 mice, we demonstrated that CIRT effectively reduces collagenous fiber synthesis and collagen production in keloid tissues. Further, CIRT was shown to inhibit keloid fibroblast proliferation and to induce apoptosis, as evidenced by increased expression of apoptosis-related proteins and confirmed through flow cytometry and TUNEL assay. Notably, CIRT induced mitochondrial stress, leading to enhanced immunogenicity of cell death, characterized by increased expression of ICD markers and secretion of interferon-γ. Additionally, CIRT promoted a shift from M2 to M1 macrophage polarization, potentially reducing TGF-β release and mitigating ECM deposition. Our findings suggest that CIRT mediates its therapeutic effects through the inhibition of the TGF-β/SMAD signaling pathway, thereby attenuating ECM formation and offering a promising avenue for keloid treatment. This study underscores the potential of CIRT as an innovative strategy for managing keloids, highlighting its multifaceted impact on key cellular processes involved in keloid pathogenesis.

Identifiants

pubmed: 39245184
pii: S0925-4439(24)00493-9
doi: 10.1016/j.bbadis.2024.167499
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167499

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Heng Zhou (H)

School of Public Health, Yangzhou University, Yangzhou, China; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.

Pengfei Yang (P)

Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.

Tianyi Zhang (T)

Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.

Oliver Kepp (O)

Centre de Recherche des Cordeliers, Université de Paris, INSERM U1138, Paris, France.

Yanxian Ren (Y)

School of Public Health, Yangzhou University, Yangzhou, China; The First Hospital of Lanzhou University, Lanzhou, China.

Ningzu Jiang (N)

School of Public Health, Yangzhou University, Yangzhou, China; The First Hospital of Lanzhou University, Lanzhou, China.

Ruifeng Liu (R)

Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China; Renmin Hospital of Wuhan Economic and Technological Development Zone, Wuhan, China.

Jin Li (J)

Renmin Hospital of Wuhan Economic and Technological Development Zone, Wuhan, China.

Chenghao Li (C)

School of Public Health, Yangzhou University, Yangzhou, China; Yangzhou University Medical College, Yangzhou, China.. Electronic address: lichenghao@126.com.

Classifications MeSH